In vascular smooth muscle, MLCK inhibits actin-myosin interaction via actin binding, which is antagonized by calcium-calmodulin.
Answers are grounded in this paper and cite their sources.
MLCK-actin inhibition in vitro warrants no clinical change; hypothesis-generating for vascular smooth muscle regulation in vivo.
Myosin light chain kinase (MLCK) was prepared from smooth muscle of bovine aorta. MLCK inhibited the ATP-dependent movement of actin filaments on a glass surface coated with smooth muscle myosin that had been phosphorylated. The inhibitory effect was abolished by calmodulin in the presence of Ca2+ (Ca-CaM). The abolition was also observed when the concentration of actin filaments was increased. The inhibitory effect and its abolition were related to the actin-binding activity of MLCK, that is antagonized by Ca-CaM.
No takes yet. Share an insight, caveat, or question.
Sato et al. (1995) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: